VAERS reports by lot

GSK Varicella/Shingles lot NX952: VAERS reports

118 VAERS reports list lot NX952 as a GSK Varicella/Shingles vaccine, received between 2018-01-30 and 2020-06-22. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
118
Reports
10%
Marked serious
1
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction13428%
General / Systemic (non-local)11323%
Musculoskeletal5211%
Neurological449%
Dermatological (non-injection-site)449%
Allergic / Anaphylactic316%
Cardiac / Cardiovascular245%
Gastrointestinal235%
Respiratory102%
Psychiatric / Neuropsychiatric61%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania12
New York12
Texas10
Michigan10
California7
Kansas5
Oregon4
Hawaii4
New Jersey4
Arizona3
Minnesota3
Georgia3

Reports by month received

2018-011
2018-026
2018-0325
2018-0440
2018-0521
2018-068
2018-075
2018-085
2018-091
2018-102
2019-021
2019-051
2019-061
2020-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.